You may be interested in a research study for adults who suffer from recurrent C. diff infections.
Participants will receive the study medication at no cost while enrolled in the study. Additionally, study-related costs such as visits, lab tests and procedures are at no cost. Participants may also be eligible for compensation for travel and time, depending on location.
This study is investigating the effectiveness and safety of a study medicine in adults with active C. diff.
Clinical trial participants should:
Be over the age of 18
Have a current C. diff infection
Be taking vancomycin to treat their infection
What happens if I sign up to pre-qualify?
We will match you to a clinical research study centre that is seeking patients with C. diff or notify you if one becomes available. Someone from the study team will contact you to explain more about the study before you make your decision to participate and see if you are eligible. This does not guarantee eligibility for the study, but the centre can perform additional reviews and tests to determine eligibility.